… associate professor of medicine at Harvard Medical School, both … pNETs, sunitinib [Sutent] is an FDA approved option. However … pause treatment or reduce the dose. In the trial, … ;www.fda.gov/drugs/;resources-information-approved-drugs/fda-approves- …

… biomarker could help inform treatment selection in the frontline … and director of Genitourinary Medical Oncology Research in New … ] phase 3 KEYNOTE-426 trial [NCT02853331], pembrolizumab [Keytruda] … was compared against sunitinib [Sutent] monotherapy, which was …

… Medical Oncology & Therapeutics Research at City of Hope, detailed treatment … note, several clinical trials are evaluating different … treatment of patients with advanced papillary RCC. Patients on the trial … nivolumab vs sunitinib (Sutent) in previously …

… an oral immunomodulatory drug for the treatment of multiple myeloma Opdivo … multinational corporation specializing in pharmaceuticals, biotechnology, and medical devices. With a … biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, …

… professor of medicine at Harvard Medical School, … Trials Network. It was a randomized, double-blinded, placebo-controlled trial … of treatment efficacy. References: 1. FDA approves … .fda.gov/drugs/;resources-information-approved-drugs/fda-approves …

… FDA announced the approval of cabozantinib for the treatment … of Medicine. The multicenter, double-blind phase 3 trial … use and previous sunitinib (Sutent) therapy in the … ;www.fda.gov/drugs/;resources-information-approved-drugs/fda-approves- …

… phase 3 CABINET trial (NCT03375320), in … Journal of Medicine showed that treatment with cabozantinib … FDA-approved systemic therapies, consisting of either everolimus (Afinitor), sunitinib (Sutent … Drug Administration (FDA) accepted the supplemental New Drug …

… and Drug Administration (FDA) has approved Cabometyx (cabozantinib) for the treatment of … epNET. The trial’s pNET cohort, the FDA reported, included … outcomes of the CABINET trial with CURE. Strosberg is … for over a decade called Sutent (sunitinib), which is …

… 2024 European Society for Medical Oncology Congress and published … advanced NET following specific treatments and as a category … 3 CheckMate-9ER pivotal trial evaluating Cabometyx (cabozantinib) in … with Pfizer Inc’s PFE Sutent (sunitinib) in the intent …

… P. Sonpavde, MD Medical Director of Genitourinary Oncology … , MD: The CheckMate 9ER trial [NCT03141177] is the randomized … 2 trial that compared cabozantinib/nivolumab vs sunitinib [Sutent].1 … the VEGF/immunotherapy trials: the median duration of …